91457-11-3Relevant articles and documents
Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: Exploring an innovative pharmacophore
Gemma, Sandra,Campiani, Giuseppe,Butini, Stefania,Kukreja, Gagan,Joshi, Bhupendra P.,Persico, Marco,Catalanotti, Bruno,Novellino, Ettore,Fattorusso, Ernesto,Nacci, Vito,Savini, Luisa,Taramelli, Donatella,Basilico, Nicoletta,Morace, Giulia,Yardley, Vanessa,Fattorusso, Caterina
, p. 595 - 598 (2007/10/03)
Identification of new molecular scaffolds structurally unrelated to known antimalarials may represent a valid strategy to overcome resistance of P. falciparum (Pf) to currently available drugs. We describe herein the investigation of a new polycyclic phar
5-(Amino or substituted amino)-1,2,3-triazoles
-
, (2008/06/13)
-
Analogues of clofibrate and clobuzarit containing fluorine in the side chains
Haydock,Mulholland,Telford,et al.
, p. 205 - 214 (2007/10/02)
A series of analogues of clofibrate and 2-[4-(4-chlorophenyl)phenylmethoxy]-2-methylpropionic acid (clobuzarit) has been prepared by replacing the methyl groups by trifluoromethyl groups and changing the aromatic moiety. The activity of these compounds has been assayed on the plasma levels of cholesterol, Total Esterified Fatty Acids (T.E.F.A.) and fibrinogen in rats. It appears that derivatives of the first series which contain only one trifluoromethyl group are hypocholesterolaemic and that many mono- of bis- trifluoromethyl derivatives of the second series lower the levels of both cholesterol and T.E.F.A. in contrast to clobuzarit.